Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

5,650.00p
   
  • Change Today:
      40.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 3,744.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 120,490
  • Market Cap: £3,715.78m
  • RiskGrade: 128

Latest ShareCast News

Genus posts rise in FY profits but warns over hit to growth

By Michele Maatouk

Date: Thursday 09 Sep 2021

(Sharecast News) - Animal genetics company Genus reported a jump in full-year profit and revenue on Thursday as it continued to win new customers, with growth in both of its business, but warned that recent volatility in the Chinese porcine market will dent growth.

Genus provides update on PRRS virus resistance programme

By Iain Gilbert

Date: Tuesday 22 Jun 2021

(Sharecast News) - Animal genetics company Genus provided an update on its porcine reproductive and respiratory syndrome virus resistance programme as part of its capital markets event on Tuesday.

Thursday broker round-up

By Caoimhe Toman

Date: Thursday 25 Feb 2021

(Sharecast News) - Medica Group: Liberum initiates at buy with a target price of 200p.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 5,650.00p
Change Today 40.00p
% Change 0.71 %
52 Week High 6,070.00
52 Week Low 3,744.00
Volume 120,490
Shares Issued 65.77m
Market Cap £3,715.78m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.62% below the market average99.62% below the market average99.62% below the market average99.62% below the market average99.62% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
63.01% above the market average63.01% above the market average63.01% above the market average63.01% above the market average63.01% above the market average
51.61% above the sector average51.61% above the sector average51.61% above the sector average51.61% above the sector average51.61% above the sector average
Income
63.89% below the market average63.89% below the market average63.89% below the market average63.89% below the market average63.89% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average
Growth
84.04% above the market average84.04% above the market average84.04% above the market average84.04% above the market average84.04% above the market average
61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 18-Nov-21 04-Mar-21
Paid 10-Dec-21 01-Apr-21
Amount 21.70p 10.30p

Trades for 17-Sep-2021

Time Volume / Share Price
16:45 74 @ 5,655.00p
16:45 74 @ 5,655.00p
16:36 1,250 @ 5,650.00p
16:35 65,811 @ 5,650.00p
16:29 5 @ 5,650.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page